Navigation Links
NTT DATA Licenses DATATRAK ONE™ for China
Date:5/29/2012

CLEVELAND, May 29, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA signed a non-exclusive license to resell DATATRAK ONE™ in the Chinese market. 

As an existing value-added reseller of DATATRAK ONE™ and Enterprise Transfer services within the Japanese market, NTT DATA extends its reach into China to deliver clinical trials with DATATRAK's cloud-based unified research platform. NTT DATA will be designing and delivering electronic clinical trials under this multi-year agreement. An added benefit of the strategic partnership is the ability to leverage NTT DATA's existing offices in China and experts to accelerate the penetration of the Chinese market.

"NTT DATA is proud to expand its global footprint by executing its Pan Asia strategy through the use of DATATRAK ONE™," commented Hidenori Chihara, NTT DATA's Senior Executive Manager Healthcare Division.  "As evident by the attendance and content of last week's DIA meeting in Shanghai, China is becoming a dynamic emerging country in the Pharmaceutical industry.  Together with DATATRAK, we are positioned to be the leader in both local and global clinical trials in China."

"This agreement creates a Pan Asian powerhouse that allows for both global companies and local Chinese companies to take advantage of our unified software suite," stated Laurence P. Birch, DATATRAK's Chairman of the Board and CEO. "We are excited about the opportunities the strategic partnership will bring as we expand the continued combination of DATATRAK's superior technology and NTT DATA's world class delivery services into the Chinese market."

DATATRAK ONE™ is a comprehensive cloud-based global clinical research platform helping customers with the strategy, planning and management of their entire life science product portfolio, including resource management, study execution needs and safety reporting.

About DATATRAK
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services™ group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I - Phase IV drug and devices studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain of the factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's quarterly report filed with the OTCQX Market on May 10, 2012 announcing its results for the three-month period ending March 31, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. MetaStat, Inc. Executes Two New Licenses
4. Insero Health Closes Initial Round of Financing and Signs Exclusive Licenses With Harvard and Yale
5. Eppendorf Licenses Technology for Thermal Cyclers to Bibby Scientific
6. Eppendorf Licenses Technology for Thermal Cyclers to Analytik Jena
7. Life Sciences Startup PhotOral Licenses Patented Oral Blue-Light Technology From Forsyth Institute
8. ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreichs Ataxia
9. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
10. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
11. ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , February 23, 2017 The fast-growing ... the United States . According to the 2017 ... industry is expected to create 283,422 jobs by 2020, with ... over the next four years. The accelerating pace of cannabis ... growth of legal cannabis market, which will further create more ...
(Date:2/23/2017)... 2017 The top three players ... Healthcare, Koninklijke Philips N.V., and Schiller. Collectively, these companies ... market in 2015. Strong product portfolio and a monumental ... be aiding these players remain leaders in the fragmented ... in the global market are likely to focus on ...
(Date:2/23/2017)... Feb. 23, 2017   SeraCare Life Sciences ... in vitro diagnostics manufacturers and clinical laboratories, is ... Implementation of NGS-Based Tests" to be hosted by ... at 11am Eastern Standard Time (US). ... the need for improved performance and global standardization ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... publication and community for those in the fight against cancer, has produced a ... their success. HRA will release top-line findings in a webinar, Defining Compassionate ...
(Date:2/23/2017)... ... 2017 , ... CALNOC, the nation’s first and only nursing quality indicators database ... Empowerment, Value and Collaboration – in Seattle, WA on October 23, 2017. , Dr. ... System in Seattle since 2000. In addition to his role at Virginia Mason, Dr. ...
(Date:2/23/2017)... Minneapolis MN (PRWEB) , ... February 23, 2017 , ... ... it is sending an expert sit stand solutions representative to the Minneapolis Home and ... 5. Location for the event that is garnering national attention is the Minneapolis Convention ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... of a new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided ... nation’s largest healthcare systems recently invested $51 million to purchase and renovate the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy has made ... is so cutting edge, in fact, the U.S. Food and Drug Administration (FDA) ... successful patient outcomes in certain clinical stem cell procedures have shown that this ...
Breaking Medicine News(10 mins):